In conclusion, based on the results presented and discussed in the foregoing sections, the integration of NASNet-Large and SVM appears a promising approach for validating RhoB as a biomarker expressed on the biopsy tissue of rectal-cancer patients. This evidence concerns the gene RHOB and rectal cancer.